Telescope Partners is a thesis-driven, early growth venture capital firm investing in exceptional entrepreneurs building enterprise software companies. Founded in 2015 and based in San Francisco, the firm partners with B2B software companies that are post product-market fit.
Founded —
Type Venture capital 4 Telescope Partners SP III, L.P. 2024-03-08 2024-03-08 $3M SeparateSPvehicleUSD3.75moffered/sold0remaining37investorsfirstsaleMarch5; regulatorysale notflagshipFundIIIclose.
Telescope Partners III, L.P. 2023-08-31 2023-08-31 — USD270mtarget0soldfirstsaleyettooccur; nodatedfinalcloseverified.
Telescope Partners II, L.P. 2020-06-12 2020-06-12 — USD120mtarget0soldinitialnotice; nofinalclosedsizeverified. SecondaryUSD148mandassetsnotcommitments.
Telescope Partners I, L.P. 2018-07-02 2018-07-02 $79M USD79.1moffered/sold0remaining15investors; firstsale2016-11-21. DebutfundroundedUSD80mcommitments inEngineannouncement. Fundformation2016 differsfirm2015claim.
SHOW MORE
$15 $5 – $30 $10 $5 – $25 — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – — — — – —
SHOW MORE
team@apexlogos.ai · 8 hours ago
Investment-fund research reviewed 2026-10-06. Publicly identified funds, dates, amounts and fundraising status are below. Undisclosed commitments remain unknown; this is not a complete register of private SPVs or parallel entities.
Fund size and vintage
Amounts below are **USD**. Form D is issuer self-reporting, not an SEC determination of accuracy; offering amounts and amount sold are kept distinct.
| Vehicle | Dated primary evidence | What is supported | Limits |
|---|---|---|---|
| Telescope Partners I, L.P., 2016 formation | [SEC Form D/A](https://www.sec.gov/Archives/edgar/data/1688528/000168852818000001/xslFormDX08/primary_doc.xml ), signed/filed 2018-07-02 | **$79.1m total offering and $79.1m sold; $0 remaining**. First sale 2016-11-21; 15 investors. | Completed offering at filing date; no separate closing announcement located. |
| Debut fund, rounded description | [Engine official funding announcement](https://engine.com/blog/hotel-engine-raises-16-million-in-series-a-funding-after-4-years-of-bootstrapped-growth ), publication date not displayed in current page; historical 2019 announcement, accessed 2026-10-06 | Describes **$80m commitments** in Telescope's debut fund. | Rounded description consistent with $79.1m filing, not a different fund. |
| Telescope Partners II, L.P., 2020 formation | [SEC initial Form D](https://www.sec.gov/Archives/edgar/data/1813749/000181374920000001/xslFormDX01/primary_doc.xml ), 2020-06-12 | **$120m offering target; $0 sold** in initial notice. | This does not establish final closed size. |
| Telescope Partners III, L.P., 2023 formation | [SEC initial Form D](https://www.sec.gov/Archives/edgar/data/1991244/000199124423000001/xslFormDX01/primary_doc.xml ), 2023-08-31 | **$270m offering target; $0 sold**, first sale yet to occur. | Latest-known numbered flagship vehicle located in this review; a final close amount/date was not verified. |
| Telescope Partners SP III, L.P. | [SEC Form D](https://www.sec.gov/Archives/edgar/data/1997394/000199739424000001/xslFormDX08/primary_doc.xml ), 2024-03-08 | **$3.75m offering and sold, $0 remaining**; first sale 2024-03-05; 37 investors. | Separate SP vehicle, not evidence that the flagship Fund III closed at $3.75m. |
A newer-fund search checked official pages and SEC-indexed results for Fund III, IV, 2025 and 2026. No independently verified Fund IV or newer flagship closing announcement was found. This is a latest-known finding, not a claim that no later fund exists.
Two secondary regulatory-data aggregators expose useful unresolved leads: [VCSpine](https://vcspine.com/firms/telescope-partners ), undated/accessed 2026-10-06, shows Fund II at $148m and calls August 2023 a last close; [Fundraising Fox](https://fundraisingfox.com/investors/telescope-partners ), profile marked verified 2026-09-29, reports approximately $328.7m, $146.2m and $296.8m gross asset values for Funds I, II and III respectively. These are **not verified final commitment sizes**. In particular, the initial Fund III filing explicitly had $0 sold, so treating that date as a completed close is unsupported. AUM/gross asset values can include appreciation and must not replace original fund commitments. Firm-wide current AUM and check sizes remain unverified.
Funds recorded in Adex after this review:
| Fund | Disclosed amount | Announcement / filing date |
| --- | --- | --- |
| Telescope Partners I, L.P. | USD 79100000 | 2018-07-02 |
| Telescope Partners II, L.P. | Undisclosed / unverified | 2020-06-12 |
| Telescope Partners III, L.P. | Undisclosed / unverified | 2023-08-31 |
| Telescope Partners SP III, L.P. | USD 3750000 | 2024-03-08 | SHOW MORE
team@apexlogos.ai · 9 hours ago
Match research 2026-10-06 / GoldiTelescopePartners / sha256:e8a47853199df305f2065a46cf0b793f90f941b5b9dfc29b3597644b335cdf7c / part 2 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
No verified semiconductor, quantum, advanced-materials, robotics or scientific-hardware investment was found in this focused review. Other baseline SaaS investments are not labeled deep tech solely because they use analytics or AI.
**Rejected attribution lead:** [Startup Intros](https://startupintros.com/orgs/telescope-partners ), updated 2026-07-13, associates the firm with Merlin Labs, Unlimited Robotics and other technical investments, but its transaction rows do not name Telescope among the participating investors. These may reflect team/prior-firm or co-investor graph contamination. They are not verified Telescope portfolio holdings and are excluded from the deep-tech evidence above.
## Neurotech and adjacent investments
**No verified neurotech investment found in the sources checked.** Searches covered Telescope's official strategy/partnership pages, the exact Adex snapshot, NFX firm and partner profiles, and searches combining the firm name with neurotechnology, neuroscience and brain. No BCI, neural recording, brain stimulation or direct neural interface investment was substantiated.
**Passage Health is relevant adjacent healthcare, not verified direct neurotechnology.** Its company-origin [funding release](https://www.einpresswire.com/article/812925303/passage-health-secures-8-million-series-a-to-transform-autism-care-with-next-generation-emr-practice-mgmt-solution ), **2025-05-20**, announces an **$8m Series A led by Telescope**, identifies partner Nicole Naidoo, and describes EMR/practice-management software for ABA/autism providers, including documentation, clinical data, scheduling and claims. Autism-care use and clinical analytics do not make the product a neural interface or brain-measurement technology. This release conflicts with the snapshot's `isLead: false`; the snapshot date of May 19 tracks its Behavioral Health Business article, while May 20 is the company release date, so both dates may be appropriate as separate reporting events.
**Canid** is vaccine-management software, not neurotech or verified biotechnology R&D. [VC News Daily](https://www.vcnewsdaily.com/access/getarticle.php?aid=nzrtpjzphg ), **2025-06-03**, reports **$10m Series A led by Telescope**, with FJ Labs, Brooklyn Bridge Ventures and SeedtoB. This is a newer transaction than the snapshot's undated $1.5m entry. EHR integration and vaccine operations do not imply investment in a vaccine developer.
## Conflicts, gaps and concrete Adex review notes
1. Preserve exact ID `GoldiTelescopePartners`; the Goldi prefix is a database identifier, not a claim that Goldi is the fund manager.
2. Review founding year: snapshot says 2015, while Engine's official announcement says 2016 and Fund I's SEC filing gives 2016 formation. These may distinguish firm establishment from fund legal formation; do not silently resolve the discrepancy.
3. Add fund evidence with proper type: Fund I $79.1m sold by July 2018; Fund II $120m initial target, final close unresolved; Fund III $270m initial target, final close unresolved. Separate SP III and current gross asset values.
4. Review Buildcheck's September 2026 investment, absent from the snapshot; use the official company release for lead status and round amount. Treat deep-tech classification as an applied-AI candidate requiring technical moat review.
5. Review apparent Fathom/Fathom Video duplicate company and round; counsel confirms one $17m Series A led by Telescope. Do not merge automatically from research alone.
6. Passage Health lead status differs from snapshot; use the company's dated announcement as stronger attribution. Keep it healthcare/autism workflow adjacent, not direct neurotech.
7. Review newer Canid June 2025 $10m Series A against the older $1.5m baseline, without assuming these are the same round.
8. Snapshot investment `amount` fields often contain the **whole company round**, while `roundAmount` is null. No source here discloses Telescope's individual check; avoid presenting round totals as its contributed capital.
9. Null check sizes remain unresolved; NFX's extracted range lacks units. Partner prior-firm investments must remain separate; do not import Signal co-investor relationships or Startup Intros graph associations as portfolio facts.
10. Coverage limits: this is a focused public-source review rather than an exhaustive transaction audit of all baseline SaaS holdings. The official portfolio extraction provides little company-level text, some reporting pages were inaccessible, and final closes for Funds II/III were not located. The absence finding concerns reviewed sources, not an assertion that the firm has no undisclosed neurotech investments.
All web sources linked above were accessed 2026-10-06; undated current pages are identified as such. Company press releases verify issuer claims but are not independent technical diligence. No database, MCP Patch, manifest or unrelated workspace files were changed. SHOW MORE
team@apexlogos.ai · 9 hours ago
Match research 2026-10-06 / GoldiTelescopePartners / sha256:e8a47853199df305f2065a46cf0b793f90f941b5b9dfc29b3597644b335cdf7c / part 1 of 2
Imported completed research. Baseline Adex/Signal statements describe prior state, not independent verification. Retain cited attribution, date, currency and classification caveats.
# Telescope Partners — GoldiTelescopePartners
- Exact Adex ID: `GoldiTelescopePartners`.
- Canonical Adex URL: https://adex.page/firms/GoldiTelescopePartners .
- Research date and source access date: **2026-10-06**.
- Status: **complete research review**, with unresolved disclosures and attribution limits explicitly identified below. Research only; no Adex changes made.
## Identity and summary
Telescope Partners is a San Francisco, thesis-driven early-growth investor in enterprise software. Its current official site supports B2B software businesses with an established market foothold and readiness to scale. It is not presented there as a dedicated hardware, scientific deep-tech or neurotechnology investor. [Official homepage](https://www.telescopepartners.com/ ) and [partnerships](https://www.telescopepartners.com/partnerships ), undated, accessed 2026-10-06.
The most technically substantive verified lead is **Buildcheck**, whose proprietary computer-vision models analyze engineering drawings; Telescope led its September 2026 Series A. This is a plausible applied-AI deep-tech candidate, with classification caveats. No verified neurotech investment found in the sources checked.
## Adex and NFX Signal starting evidence
The exact saved snapshot, `data/research/_sources/GoldiTelescopePartners.adex.json`, was retrieved 2026-10-06 at 19:29:02 UTC from read-only MCP Search. It contains the correct firm name and ID, a description of early-growth B2B software investing, San Francisco location, a founding-year claim of 2015 within the description (the structured `founded` field is null), 14 roles and 19 investment participations. `checkMin`, `checkMax` and `sweetSpot` are null. Fund sizes are absent.
Baseline participation names are Passage Health, Fundraise Up, Fathom, Stay AI, Uniqode, Sesame, Measured, MedTrainer, Engine, Bravely, Topbox, Brandfolder, Brightfield, Canid, Fathom Video and Gipper; repeated records exist for Stay AI and Gipper. These are research leads, not independent corroboration. Some source evidence is generic Goldi or low-context aggregators. The snapshot does not contain Buildcheck's September 2026 round.
[NFX Signal firm page](https://signal.nfx.com/firms/telescope-partners ), undated, was directly read. It shows the firm and co-investor links, but the rendered team section lacks usable strategy or fund disclosures. Co-investor links alone cannot establish an investment in any specific company.
[NFX Ripley Carroll profile](https://signal.nfx.com/investors/ripley-carroll ), undated, directly read, identifies him as Principal at Telescope Partners and displays investment range `$5 - $30`, sweet spot `$15`, and 14 investments. The extracted display omits magnitude units: **do not convert this to a $5–30 million check range without checking the full rendered profile**. Records attached to a person's profile can include prior-firm history, so they are not automatically Telescope investments. Signal is secondary starting evidence, not verified firm disclosure.
## Fund size and vintage
Amounts below are **USD**. Form D is issuer self-reporting, not an SEC determination of accuracy; offering amounts and amount sold are kept distinct.
| Vehicle | Dated primary evidence | What is supported | Limits |
|---|---|---|---|
| Telescope Partners I, L.P., 2016 formation | [SEC Form D/A](https://www.sec.gov/Archives/edgar/data/1688528/000168852818000001/xslFormDX08/primary_doc.xml ), signed/filed 2018-07-02 | **$79.1m total offering and $79.1m sold; $0 remaining**. First sale 2016-11-21; 15 investors. | Completed offering at filing date; no separate closing announcement located. |
| Debut fund, rounded description | [Engine official funding announcement](https://engine.com/blog/hotel-engine-raises-16-million-in-series-a-funding-after-4-years-of-bootstrapped-growth ), publication date not displayed in current page; historical 2019 announcement, accessed 2026-10-06 | Describes **$80m commitments** in Telescope's debut fund. | Rounded description consistent with $79.1m filing, not a different fund. |
| Telescope Partners II, L.P., 2020 formation | [SEC initial Form D](https://www.sec.gov/Archives/edgar/data/1813749/000181374920000001/xslFormDX01/primary_doc.xml ), 2020-06-12 | **$120m offering target; $0 sold** in initial notice. | This does not establish final closed size. |
| Telescope Partners III, L.P., 2023 formation | [SEC initial Form D](https://www.sec.gov/Archives/edgar/data/1991244/000199124423000001/xslFormDX01/primary_doc.xml ), 2023-08-31 | **$270m offering target; $0 sold**, first sale yet to occur. | Latest-known numbered flagship vehicle located in this review; a final close amount/date was not verified. |
| Telescope Partners SP III, L.P. | [SEC Form D](https://www.sec.gov/Archives/edgar/data/1997394/000199739424000001/xslFormDX08/primary_doc.xml ), 2024-03-08 | **$3.75m offering and sold, $0 remaining**; first sale 2024-03-05; 37 investors. | Separate SP vehicle, not evidence that the flagship Fund III closed at $3.75m. |
A newer-fund search checked official pages and SEC-indexed results for Fund III, IV, 2025 and 2026. No independently verified Fund IV or newer flagship closing announcement was found. This is a latest-known finding, not a claim that no later fund exists.
Two secondary regulatory-data aggregators expose useful unresolved leads: [VCSpine](https://vcspine.com/firms/telescope-partners ), undated/accessed 2026-10-06, shows Fund II at $148m and calls August 2023 a last close; [Fundraising Fox](https://fundraisingfox.com/investors/telescope-partners ), profile marked verified 2026-09-29, reports approximately $328.7m, $146.2m and $296.8m gross asset values for Funds I, II and III respectively. These are **not verified final commitment sizes**. In particular, the initial Fund III filing explicitly had $0 sold, so treating that date as a completed close is unsupported. AUM/gross asset values can include appreciation and must not replace original fund commitments. Firm-wide current AUM and check sizes remain unverified.
## Investment stages
Current mandate: early growth, enterprise/B2B software businesses beyond the idea stage, with demonstrated products and market footholds. This is supported by the [official homepage](https://www.telescopepartners.com/ ) and [partnerships page](https://www.telescopepartners.com/partnerships ), undated/accessed 2026-10-06. No reliable fixed seed-to-Series-B mandate or minimum revenue threshold was disclosed on those pages.
Historical **Series A** activity is directly supported by Buildcheck (2026), Passage Health (2025), Fathom (2024), and Engine's $16m first outside round, led by Telescope, described in the [official Engine announcement](https://engine.com/blog/hotel-engine-raises-16-million-in-series-a-funding-after-4-years-of-bootstrapped-growth ). These transactions demonstrate Series A investing; they do not prove that every Series A or seed company fits the current mandate. Baseline historical seed/growth labels require case-by-case verification.
## Named deep-tech investments and classification
| Company | Firm attribution, round/date | Technology rationale | Assessment and supporting source |
|---|---|---|---|
| **Buildcheck / Buildcheck AI, Inc.** | Telescope **led $12m Series A**, announced **2026-09-09**; other participants WND Ventures, Uncork Capital, Salt VC and Xfund. Total company funding stated $18m. | Proprietary computer-vision models read construction blueprints and check for errors, omissions and coordination conflicts. | Strongest verified applied-AI candidate. Company-origin release establishes proprietary models, but not their scientific novelty, patents or fundamental R&D moat; do not assert a confirmed scientific deep-tech classification. [Buildcheck release via GlobeNewswire](https://www.globenewswire.com/de/news-release/2026/09/09/3358881/0/en/buildcheck-raises-12m-series-a-to-equip-construction-teams-with-vision-based-ai-for-drawing-reviews.html ), 2026-09-09; [CEO announcement](https://buildcheck.ai/insights-case-studies/buildcheck-announces-series-a-funding ), 2026-09-09. $12m is company round size, not Telescope's disclosed individual check. |
| **Fathom / Fathom Video Inc.** | Telescope **led $17m Series A**, **2024-09-19**. | AI/NLP meeting transcription, summarization and analysis. | Verified AI software investment, but insufficient evidence for strict deep tech: an AI product alone does not establish scientific novelty. [Company counsel Silicon Legal](https://www.siliconlegal.com/sls-client-fathom-raises-17mm-round-from-telescope-partners-and-others/ ), 2024-09-19, confirms client representation, round, attribution and technology. The baseline Fathom and Fathom Video records appear to describe the same round, not distinct companies. | SHOW MORE
team@apexlogos.ai · 22 days ago
MATCH 
Alumni Ventures
Sesame$250M · 2022-06-14
General Catalyst
Primary Venture Partners
Bravely$— · 2021-08-24
BuildCheck
Canid
Passage Health
Fundraise Up
Fathom Video
Fathom
Stay AI
Uniqode
Measured
MedTrainer
Engine
Topbox
Brandfolder
Gipper
Brightfield